Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 5, 2014, Pages 1522-1526

  Steinmann, J ^a   Hamprecht, A ^b   Vehreschild, M J G T ^c,d   Cornely, O A ^c,d,e   Buchheidt, D ^f   Spiess, B ^f   Koldehoff, M ^a   Buer, J ^a   Meis, J F ^g,h   Rath, P M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d German Center for Infection Research (DZIF)   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillus fumigatus; Azole resistance; Haematopoietic stem cell transplant recipients

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ITRACONAZOLE; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE; VORICONAZOLE; ANTIFUNGAL AGENT; CYTOCHROME P-450 CYP51A, ASPERGILLUS; CYTOCHROME P450; FUNGAL PROTEIN; MICROSATELLITE DNA; MUTANT PROTEIN;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CONTROLLED STUDY; FEMALE; FRANCE; FUNGUS ISOLATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GERMANY; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INDIA; INVASIVE ASPERGILLOSIS; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; SHORT TANDEM REPEAT; ADVERSE EFFECTS; AMINO ACID SUBSTITUTION; ANTIFUNGAL RESISTANCE; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECTS; GENETICS; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MOLECULAR TYPING;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DRUG RESISTANCE, FUNGAL; FEMALE; FUNGAL PROTEINS; GENOTYPE; GERMANY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MICROBIAL SENSITIVITY TESTS; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR TYPING; MUTANT PROTEINS; MYCOLOGICAL TYPING TECHNIQUES; SEQUENCE ANALYSIS, DNA;

EID: 84929751965     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku566     Document Type: Article

References (20)

1. Upton A, Kirby KA, Carpenter P et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-40.
2. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis:clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
3. Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Böhme A, Ruhnke M et al. Treatment of invasive fungal infections in cancer patients-recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2009; 88: 97-110.
4. Chowdhary A, Kathuria S, Xu J et al. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 2013; 9: e1003633.
5. Chowdhary A, Kathuria S, Randhawa HS et al. Isolation of multipletriazole- resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India. J Antimicrob Chemother 2012; 67: 362-6.
6. van der Linden JW, Camps SM, Kampinga GA et al. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 2013; 57:513-20.
7. van der Linden JW, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 2011; 17: 1846-54.
8. Bader O, Weig M, Reichard U et al. cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother 2013; 57: 3513-7.
9. Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 2013; 26: 493-500.
10. Fischer J, van Koningsbruggen-Rietschel S, Rietschel E et al. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients. J Antimicrob Chemother 2014; 69: 1533-6.
11. Vermeulen E, Maertens J, Schoemans H et al. Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 2012; 17: pii1/420326.
12. Astvad KM, Jensen RH, Hassan TM et al. First detection of TR46/Y121F/ T289A and of TR34/L98H in azole naive patients in Denmark despite negative findings in the environment. Antimicrob Agents Chemother 2014; 58:5096-101.
13. Chowdhary A, Sharma C, Kathuria S et al. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India. J Antimicrob Chemother 2014; 69: 555-7.
14. Chowdhary A, Kathuria S, Xu J et al. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS One 2012; 7: e52871.
15. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-21.
16. Hamprecht A, Buchheidt D, Vehreschild JJ et al. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany. Euro Surveill 2012; 17: pii1/420262.
17. Rath PM, Buchheidt D, Spiess B et al. First reported case of azoleresistant Aspergillus fumigatus due to the TR/L98H mutation in Germany. Antimicrob Agents Chemother 2012; 56: 6060-1.
18. Camps SM, Rijs AJ, Klaassen CH et al. Molecular epidemiology of Aspergillus fumigatus isolates harboring the TR34/L98H azole resistance mechanism. J Clin Microbiol 2012; 50: 2674-80.
19. Seyedmousavi S, Hashemi SJ, Zibafar E et al. Azole-resistant Aspergillus fumigatus, Iran. Emerg Infect Dis 2013; 19: 832-4.
20. Denning DW, Bowyer P. Voriconazole resistance in Aspergillus fumigatus:should we be concerned? Clin Infect Dis 2013; 57: 521-3.